Patents
Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118)
04/2004
04/22/2004US20040077617 for example 3-methylbicyclo[4.1.0]heptane-7-carboxylic acid or N-(2-amino-2-oxoethyl)-4,7,7-trimethyltricyclo [4.1.1.02,4]octane-3-carboxamide; use treating epilepsy, bipolar disorder, migraine, neuropathic and inflammatory pain
04/22/2004US20040077600 Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
04/22/2004US20040077021 Haptens, intermediates, and immunogens that are useful in the production of antibodies specific for the methylenedioxy class of amphetamine derivatives
04/22/2004CA2501831A1 Activity-based probes, and methods of their preparation and use
04/21/2004EP1408987A2 Tetracycline compounds having target therapeutic activities
04/21/2004EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
04/21/2004CN1491208A Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical
04/21/2004CN1491207A Acylated indanyl amines and their use as pharmaceuticals
04/21/2004CN1490307A Industrial production of benzofloxamide
04/21/2004CN1490306A Carbon 13 labeled ledocaine and its salts preparations and uses
04/20/2004US6723753 Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
04/20/2004US6723743 Treating patient suffering from rheumatoid arthritis, psoriasis, bronchial asthma, alzheimer's disease, myocardial infarction or atherosclerosis
04/15/2004WO2004006850A3 3, 10, AND 12a SUBSTITUTED TETRACYCLINE COMPOUNDS
04/15/2004US20040073026 Cyclic protein tyrosine kinase inhibitors
04/15/2004US20040072854 Antiemetics; psychlogical disorders; antidepressants; anxiolytic agents; antitussive agents
04/15/2004US20040072770 Methods for specifically inhibiting histone deacetylase-7 and 8
04/15/2004US20040072341 Bioactive oligopeptides
04/15/2004US20040071851 Novel N-alkylaspartyl amide derivative and sweetening agent
04/14/2004EP1406862A1 Substituted aminoalcohols useful in treatment of alzheimer's disease
04/14/2004EP1406617A1 Diaminediols for the treatment of alzheimer's disease
04/14/2004EP1406493A1 Administration of agents via the pept-2 transporter
04/14/2004EP1286954B1 7-substituted fused ring tetracycline compounds
04/14/2004EP1109781B1 Process to continuously prepare an aqueous mixture of epsilon-caprolactam and epsilon-caprolactam precursors
04/14/2004EP1100772B1 Open chain alkoxyamine compounds and their use as polymerization regulators
04/14/2004EP1073641B1 New substituted amides, their production and their use
04/14/2004EP0724561B1 Calcium receptor-active arylalkyl amines
04/14/2004CN1145608C Quanternary ammonium compounds as anti-tussive agents
04/13/2004US6720452 Adamantane derivatives
04/13/2004US6720169 By converting the corresponding acetal-protected aldehyde into the corresponding aminonitrile, converting the aminonitrile into the corresponding amino acid amide, and performing enzymatic, enantioselective hydrolysis
04/13/2004US6719958 Polychelants, their complexes with metal ions, their preparation and their uses
04/08/2004WO2004029018A1 Glycerol derivative
04/08/2004WO2004016580A3 Derivatives of glycinergic r(+)-2-amino-3-hydroxypropanoic acid
04/08/2004WO2002032856A9 Insecticidal 1,8-naphthalenedicarboxamides
04/08/2004US20040068013 Supplying in situ using amino acid; immobilization
04/08/2004US20040068007 Diclofenac salt of lidocaine
04/08/2004US20040067979 N-bridged selective androgen receptor modulators and methods of use thereof
04/08/2004US20040067912 Microbiocides, antibiotic, antitumor agent
04/08/2004US20040067525 Method for structural analysis of organic compound
04/07/2004EP1405845A1 Method for purifying n2-(1(s)-ethoxycarbonyl-3-phenylpropyl)-n6-trifluoroacetyl-l-lysine
04/07/2004EP1405646A2 Pharmaceutically acceptable salts of local anaesthetics with anti-inflammatory compounds and methods for preparing the same
04/07/2004EP1404664A1 Aminediols for the treatment of alzheimer's disease
04/07/2004EP1404328A1 Alpha-hydroxyamide statine derivatives for the treatment of alzheimer's disease
04/07/2004EP1404322A2 1-butane acid derivatives, pharmaceutical compositions containing said derivatives and the use thereof
04/07/2004EP1240132B1 Adamantane derivatives
04/07/2004CN1486690A Medicinal salt with local narcosis and antiphlogosis activity and its prepn process
04/06/2004US6716818 Caspase inhibitors and the use thereof
04/06/2004CA2190992C Naphthalene derivatives
04/06/2004CA2075926C Hydroquinone amino-acid esters, method of preparation, and pharmaceutical or cosmetic compositions containing them
04/03/2004CA2453071A1 Genes and proteins for the production of polyene polyketides
04/01/2004WO2004026814A2 Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors
04/01/2004WO2004005478A3 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
04/01/2004US20040063959 Esters and amides as PLA2 inhibitors
04/01/2004US20040063904 Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors
04/01/2004US20040063783 Used to treat pathologies characterized by an oxidative stress condition and a lack of availability of endothelial nitrogen monoxide, such as ischemia, restenosis, erectile dysfunction, hypoxia, transplant rejection and diabetes
04/01/2004US20040063686 Diabetes, major depression, manic depression, anxiety, schizophrenia, sleep disorders
04/01/2004US20040063674 Tetracycline compounds having target therapeutic activities
04/01/2004US20040062773 Compositions for the delivery of antigens
04/01/2004CA2498759A1 Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors
03/2004
03/31/2004EP1403247A1 N-Alkanoylphenylalanine derivatives
03/31/2004EP0770065B1 Tri-substituted phenyl derivates useful as pde iv inhibitors
03/31/2004CN1486302A Abca-1 elevating compounds against coronary artery disease or atherosclerosis
03/31/2004CN1486298A Prodrugs of excitatory amino acids
03/30/2004US6713650 ABCA-1 elevating compounds
03/30/2004US6713635 As chemical intermediates used for the preparation of s-alpha-ethyl-2-oxo-1-pyrrolidine acetamide
03/30/2004US6713517 Using n-(2-diethylamino-ethyl)-4-amino-3-chlorobenzamide
03/30/2004US6713514 Such as 2-(benzylamino)-3-(4-(n-(3-phenylpropyl)carbamoyl)-phenyl)propanoic acid
03/25/2004WO2004024755A2 Sarcolysyl derivatives and method for the production thereof
03/25/2004WO2004024675A1 Substituted aminoethers for the treatment of alzheimer's disease
03/25/2004WO2003072528A3 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
03/25/2004WO2003057721A3 Substituted amino carboxamides for the treatment of alzheimer's disease
03/25/2004WO2003048106A3 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof
03/25/2004WO2002088085A3 Methods and intermediates for preparing 4-aminoquinoline cetp inhibitors
03/25/2004US20040059149 Method for the synthesis of compounds of formula 1 and derivatives thereof
03/25/2004US20040058991 Anticonvulsants; central nervous system disorders
03/25/2004US20040058916 Central nervous system disorders; psychological disorders; schizophrenia; antiarthritic agents; Alzheimer's disease; anticancer agents
03/25/2004US20040058820 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
03/25/2004CA2498269A1 Substituted aminoethers for the treatment of alzheimer's disease
03/24/2004EP1399414A2 Substituted tetracycline compounds for the treatment of malaria
03/24/2004EP0784469B1 Compositions for the delivery of antigens
03/24/2004CN1483723A Method for purifying ioversol
03/24/2004CN1142907C Process to continuously prepare aqueous mixture of epsi-caprolacta and epsi caprolactam precursors
03/23/2004US6710089 Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
03/20/2004CA2406504A1 Method of treating resistant tumors
03/18/2004WO2004022541A1 1,4-substituted cyclohexane derivatives
03/18/2004WO2004022523A2 1, 3-diamino-2-hydroxypropane prodrug derivatives
03/18/2004WO2003099763A8 N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors
03/18/2004WO2003099192A3 Bis-aromatic alkanols
03/18/2004WO2003097576A3 Diamino-functional chalcones
03/18/2004WO2003047499A3 Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting
03/18/2004US20040054186 Autoimmune diseases; anticancer agents; antiproliferative agents; skin disorders
03/18/2004US20040053916 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
03/18/2004US20040053907 Cell adhesion inhibitors
03/18/2004US20040053786 Insecticidal 1,8-naphthalenedicarboxamides
03/18/2004DE10239832A1 New sarcolysine derivatives, e.g. amide or peptide compounds, useful as anticancer agents with reduced toxicity to healthy cells
03/18/2004CA2497979A1 1, 3-diamino-2-hydroxypropane prodrug derivatives
03/17/2004EP1397370A1 B-benzyloxyaspartate derivatives with amino group on benzene ring
03/17/2004EP1242364B1 Adamantane derivatives
03/17/2004EP1144365B1 Inhibitors of alpha-4 beta-1 mediated cell adhesion
03/17/2004EP1003558B1 Lipid-polyamide conjugates and compositions for nucleic acid delivery
03/17/2004EP0998488B1 Polyol-amino acid compounds having anti-helicobacter pylori activity
1 ... 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 ... 162